Nov 2020 Research Articles
Incidentally detected acromegaly: single-center study of surgically treated patients over 22 years.
Editor’s note: Drs. Oyesiku and Ioachimescu are members of the PNA.
Pegvisomant and Pasireotide LAR as second line therapy in acromegaly: Clinical effectiveness and predictors of response.
Editor’s note: Dr. Fleseriu is a member of the PNA.
EGFR/ErbB2 targeting lapatinib therapy for aggressive prolactinomas.
Editor’s note: Drs. Yuen, Fleseriu and Melmed are members of the PNA.